These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1301246)

  • 1. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide].
    Kleber FX; Nussberger J; Niemöller L; Doering W; Brunner H
    Z Kardiol; 1991; 80 Suppl 8():111-2. PubMed ID: 1839102
    [No Abstract]   [Full Text] [Related]  

  • 4. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).
    Kleber FX; Reindl I; Wenzel M; Rodewyk P; Beil S; Kosloswki B; Doering W; Sabin GV; Hinzmann S; Winter UJ
    Herz; 1993 Dec; 18 Suppl 1():424-9. PubMed ID: 8125422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment with captopril after acute myocardial infarction.
    Ray SG; Pye M; Oldroyd KG; Christie J; Connelly DT; Northridge DB; Ford I; Morton JJ; Dargie HJ; Cobbe SM
    Br Heart J; 1993 Mar; 69(3):215-22. PubMed ID: 8461219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis of mild chronic heart failure: effects of the ACE inhibitor captopril].
    Kleber FX; Doering W
    Herz; 1991 Sep; 16 Spec No 1():283-93. PubMed ID: 1820294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
    Pfeffer MA
    Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute filling pattern changes of the failing left ventricle after captopril as related to ventricular structure.
    Barbier P; Tamborini G; Alioto G; Pepi M
    Cardiology; 1996; 87(2):153-60. PubMed ID: 8653733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition.
    Foy SG; Crozier IG; Richards AM; Nicholls MG; Turner JG; Frampton CM; Ikram H
    Eur Heart J; 1995 Jun; 16(6):770-8. PubMed ID: 7588920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
    Rouleau JL; Packer M; Moyé L; de Champlain J; Bichet D; Klein M; Rouleau JR; Sussex B; Arnold JM; Sestier F
    J Am Coll Cardiol; 1994 Sep; 24(3):583-91. PubMed ID: 7915733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of left ventricular dysfunction following myocardial infarction.
    Sharpe N
    Herz; 1991 Sep; 16 Spec No 1():272-7. PubMed ID: 1820293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.
    Pfeffer MA; Lamas GA; Vaughan DE; Parisi AF; Braunwald E
    N Engl J Med; 1988 Jul; 319(2):80-6. PubMed ID: 2967917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of early use of captopril on haemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction.
    Galcera-Tomas J; Nuño de la Rosa JA; Torres-Martinez G; Rodriguez-Garcia P; Castillo-Soria FJ; Canton-Martinez A; Campos-Peris JV; Pico-Aracil F; Ruiz-Ros JA; Ruiperez-Abizanda JA
    Eur Heart J; 1993 Feb; 14(2):259-66. PubMed ID: 8449203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
    Kayanakis JG; Breton J; Maillet J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1369-74. PubMed ID: 6422872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
    St John Sutton M; Pfeffer MA; Plappert T; Rouleau JL; Moyé LA; Dagenais GR; Lamas GA; Klein M; Sussex B; Goldman S
    Circulation; 1994 Jan; 89(1):68-75. PubMed ID: 8281697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
    Pfeffer MA; Braunvald Iu; Moĭe LA; Basta L; Braun EDzh ; Kaddi TE; Dévis BR; Geltman EM; Goldman S; Fleĭker GS
    Kardiologiia; 1993; 33(12):14-23, 3. PubMed ID: 7910865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.